Urologix, Inc. reported revenue results for the fourth quarter and full year of fiscal 2013. Fourth quarter fiscal year 2013 revenue totaled approximately $4.2 million, up approximately 2.5% sequentially from the third quarter of fiscal year 2013 and down approximately 7% compared to the fourth quarter of fiscal year 2012.

Fiscal year 2013 revenue totaled approximately $16.6 million, down approximately 3% year-over-year, and in-line with the company's fiscal year guidance range of $16 million to $17 million.